Moving Forward in HIV-Associated Cancer
Year: 2014
Type: article
Abstract: Cancer has been linked to HIV since the earliest days of the epidemic. The unusually frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in 1981 was a sentinel observation leading to the inclusion of KS in the first AIDS case definition.1,2 More than three decades later, major research investments have led to striking advances in understanding HIV pathogenesis, with antiretroviral therapy (ART) reducing AIDS complications and allowing HIV-infected individuals to experience life expectancy approaching that of persons without HIV.3,4
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1531094742, Developing a clinical cohort of histopathologically characterized lymphoma, G2127051194, G257334518, G5552972005, AIDS Malignancy Clinical Trials Consortium (AMC), G656578969, CFAR Network of Integrated Clinical Systems (CNICS), The University of North Carolina Center for AIDS Research, Cancer Center Support Grant
OpenAlex ID: W2113748050